Verve Therapeutics, Inc. (VERV) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-07-25

Verve Therapeutics, Inc. (VERV) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every VERV SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Verve Therapeutics, Inc. (VERV)

SEC CIK	0001840574

Recent VERV Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-07-25	ADELMAN BURT A	Insider	J — Other acquisition / disposition	428.3K	—	—	SEC
2025-07-25	Yeshwant Krishna	Insider	J — Other acquisition / disposition	6.11M	—	—	SEC
2025-07-25	Yeshwant Krishna	Insider	J — Other acquisition / disposition	4.26M	—	—	SEC
2025-07-25	Yeshwant Krishna	Insider	J — Other acquisition / disposition	1.80M	—	—	SEC
2025-07-25	Dorval Allison	Chief Financial Officer	J — Other acquisition / disposition	13.3K	—	—	SEC
2025-07-25	Ashe Andrew D.	See Remarks	J — Other acquisition / disposition	348.8K	—	—	SEC
2025-07-25	Nickerson Joan	Chief Administrative Officer	J — Other acquisition / disposition	17.4K	—	—	SEC
2025-07-25	GV 2017 GP, L.L.C.	Insider	J — Other acquisition / disposition	6.11M	—	—	SEC
2025-07-25	GV 2017 GP, L.L.C.	Insider	J — Other acquisition / disposition	4.26M	—	—	SEC
2025-07-25	GV 2017 GP, L.L.C.	Insider	J — Other acquisition / disposition	1.80M	—	—	SEC
2025-07-25	Kathiresan Sekar	Chief Executive Officer	J — Other acquisition / disposition	348.4K	—	—	SEC
2025-07-25	Kathiresan Sekar	Chief Executive Officer	J — Other acquisition / disposition	111.0K	—	—	SEC
2025-07-25	Kathiresan Sekar	Chief Executive Officer	J — Other acquisition / disposition	241.0K	—	—	SEC
2025-07-25	Politi Jason	Chief Technical Ops. Off.	J — Other acquisition / disposition	16.4K	—	—	SEC
2025-07-25	Lister Troy	Chief Scientific Officer	J — Other acquisition / disposition	7.0K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Verve Therapeutics, Inc. (VERV). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2025-07-25 — MacLean Michael F (Insider)
2025-07-25 — Yeshwant Krishna (Insider)
2025-07-25 — COATS LONNEL (Insider)
2025-07-25 — Dorval Allison (Chief Financial Officer)
2025-07-25 — ADELMAN BURT A (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in VERV insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

VERV Insider Trading — FAQ

What is the latest insider trade for VERV?: Verve Therapeutics, Inc. (VERV) had 0 insider filings in the last 90 days, with the most recent on 2025-07-25. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying VERV stock?: 0 insider purchases of VERV were filed in the last 90 days.
How many insiders are selling VERV stock?: 0 insider sales of VERV were filed in the last 90 days.
Where can I see VERV SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every VERV SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live VERV dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.